Discover 2,380 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Plainfield offers many clinical trial opportunities with focuses on various conditions, including ADHD, prurigo nodularis, autoimmune diseases like lupus, and cardiovascular conditions. The city's leading institutions are actively recruiting both healthy volunteers interested in paid research options, as well as those with specific health conditions for studies that could lead to groundbreaking discoveries and improved treatments.
Filter
2
Filter results
Results: 2,380
Impact of Sensor Technology in Knee OA
for
Knee Osteoarthritis
Location: Chicago IL
Sponsor: OPUM Technologies US LTD
Sex: All
Age: 40 - 70+
Code: NCT05222503
Recruiting
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
for
Schizophrenia
Location: Chicago IL, Ann Arbor MI, West Chester OH,
Sponsor: MapLight Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07459647
Phase 2, Recruiting
Combination Therapy to Improve SCI Recovery.
for
Spinal Cord Injuries
Location: Chicago IL, Cambridge MA
Sponsor: Spaulding Rehabilitation Hospital
Sex: All
Age: 18 - 70
Code: NCT05563103
Recruiting
Timing and Dosage of Acute Intermittent Hypoxia in Persons With SCI
for
Spinal Cord Injuries
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab
Sex: All
Age: 18 - 70
Code: NCT03774043
Phase 1, Phase 2, Recruiting
Promoting Recovery Outcomes Through Precise Early Locomotor Interventions in Persons With Spinal Cord Injury
for
Spinal Cord Injuries
Location: Chicago IL
Sponsor: Milap Sandhu
Sex: All
Age: 16 - 70+
Code: NCT06176833
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Double Dose 4-AP on Functional Recovery After Spinal Cord Injury
for
SCI - Spinal Cord Injury
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab
Sex: All
Age: 18 - 70+
Code: NCT06853015
Phase 1, Phase 2, Recruiting
EAT: A Reliable Eating Assessment Technology for Free-living Individuals
for
Wearable Electronic Device
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT06118528
Recruiting
Choice and Autonomy in Learning Mindfulness for Pediatric Residents
for
Program Engagement, Treatment Adherence and Compliance,
Location: Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 0+
Code: NCT07542769
Recruiting
Telehealth Implementation of Brain-Computer Interface
for
Amyotrophic Lateral Sclerosis, Stroke
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab
Sex: All
Age: 16 - 70+
Code: NCT05951556
Recruiting
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
for
Acute Myeloid Leukemia Post Cytotoxic Therapy,
Location: Chicago IL, Ann Arbor MI, Cincinnati OH, Minneapolis MN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT07012044
Phase 1, Recruiting
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
for
Achondroplasia
Location: Chicago IL, Cincinnati OH, Baltimore MD,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 2 - 17
Code: NCT07441876
Phase 2, Phase 3, Recruiting
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Location: Skokie IL, Bethesda MD, Spokane WA, Las Vegas NV
Sponsor: Newave Pharmaceutical Inc
Sex: All
Age: 18+
Code: NCT07342478
Phase 3, Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Chicago IL, Indianapolis IN, St Louis MO,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT04485559
Phase 1, Recruiting
Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma